-+ 0.00%
-+ 0.00%
-+ 0.00%

FRESENIUS ANNOUNCES FDA APPROVAL OF RITUXIMAB BIOSIMILAR FOR THE U.S. MARKET

路透·08/03/2026 20:09:06

登錄查看新聞詳情